hepatotoxic effect related to ganoderma lucidum lingzhi mushroom powder was first described in a patient from hong kong in 2004in 2005 the authors experienced a case of fatal fulminant hepatitis associated with such a preparationboth patients had taken other therapeutic agents and traditionally boiled lingzhi without any toxic effectafter switching to taking lingzhi in powder form for 12 months the hepatotoxic episode occurred in both patientsthe toxic role of lingzhi powder needs close monitoring in the future especially in combination with other drugs